July 12, 2012 08:05 ET

Equity Research on Rite Aid Corp. and CVS Caremark Corporation -- Drug Stores Feeling Generic Pinch

NEW YORK, NY--(Marketwire - Jul 12, 2012) - has a handpicked team of market professionals with over 100 years of combined investing experience. Today they are providing members comprehensive research on the Drug Stores industry and are offering free analytical research on Rite Aid Corp. (NYSE: RAD) and CVS Caremark Corporation (NYSE: CVS). Register with us now to have free access to these research reports. Simply click on the link below.

While the upholding of the Affordable Care Act could work in favor of the drugstores industry and companies such as Rite Aid Corp. and CVS Caremark Corporation, several headwinds are currently creating challenges. With many blockbuster drugs losing exclusivity, cheaper generics are having a negative impact on sales. For example, Rite Aid recently reported that for the four weeks ended June 30th, same-store sales fell by one percent when compared year-over-year. Rite Aid Corp. report is accessible for free by registering today at is the Ultimate Trading Environment for investors. If you are considering owning Rite Aid Corp. and CVS Caremark Corporation then you should sign up for a free membership and our complimentary reports today. Over the last 5 years our returns outpaced any of the major indexes. Sign up today by clicking on the link below to find out what you are missing.

Although pharmacy sales may be sliding, a number of companies have been offsetting this by successfully increasing front-end sales. New products have led several companies higher, and those that come up with the right product mix could continue to outperform their peers. Get your free reports on Rite Aid Corp. and CVS Caremark Corporation at There is no commitment to join.

Companies that offer dividends, such as CVS Caremark, have also been garnering added investor attention as of late, as individuals look for ways to grow their investments in unstable times. CVS Caremark recently approved a quarterly dividend of $0.1625 per share. CVS Caremark Corporation report is accessible for free by registering today at

The two Drug Stores stocks research reports are available for free by signing up now on the link below.

Shine's Rooms is the brainchild of David Shine, a 13-year Wall Street veteran with a stellar track record. For 13 years Shine has trained thousands of traders to navigate and profit from the markets. Using cutting-edge technology, Shine provides you with a community in which you can trade alongside Shine and his Team as they guide you through the market's ever-changing landscape.

To view our disclaimer, visit this link

Contact Information